Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.

Date publication

septembre 2024

Journal

Neurology(R) neuroimmunology & neuroinflammation

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Oertel FC, Zimmermann HG, Motamedi S, Bereuter C, Manthey LM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, D'Cunha A, Aktas O, Albrecht P, Ringelstein M, Martinez-Lapiscina EH, Sanchez Dalmau BF, Villoslada P, Asgari N, Marignier R, Cobo-Calvo A, Leocani L, Pisa M, Radaelli M, Palace J, Roca-Fernandez A, Leite MIS, Sharma S, De Seze J, Senger T, Yeaman MR, Smith TJ, Cook LJ, Brandt AU, Paul F,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38941573

Résumé

To systematically describe the clinical picture of double-antibody seronegative neuromyelitis optica spectrum disorders (DN-NMOSD) with specific emphasis on retinal involvement.

Mots clés

Humans, Neuromyelitis Optica, diagnostic imaging, Female, Male, Adult, Cross-Sectional Studies, Middle Aged, Tomography, Optical Coherence, Aquaporin 4, immunology, Retrospective Studies, Autoantibodies, blood, Retina, diagnostic imaging

Référence

Neurol Neuroimmunol Neuroinflamm. 2024 09;11(5):e200273